Mammalian Derived Proteins Market Overview
Mammalian derived proteins are the proteins are isolated from the mammalian system are of gold standard in therapeutic applications. For instance, mammalian derived proteins are extensively used for manufacturing monoclonal antibody (MAB), clotting factors and hormones due to the highest possibility of proper binding activity. The capability of mammalian cell cultures to synthesize large and complex protein molecules and high tolerance to environmental changes will drive the mammalian derived protein market. Mouse myeloma and Chinese hamster ovary cell systems are being conventionally used for producing mammalian derived proteins. Using human cell lines to produce mammalian derived proteins is the current trend in the market which is expected to fuel the growth of the market. Technological advancements in Genome engineering has developed various approaches of expression and isolation of proteins for research purpose.
Mammalian Derived Proteins Market: Drivers and Restraints
Rising prevalence of chronic diseases (cancer and heart diseases) act as the biggest driver for mammalian derived proteins. More recently, the rise in fertility problems across the globe has increased the consumption of hormonal therapies. This will drive the mammalian derived protein market globally as most of the fertility hormones are developed through the mammalian cell cultures. The high cost of protein production will act as the biggest restraint for mammalian derived protein market. The difficulty of handling mammalian cells can restrict the growth of mammalian derived protein market. Besides, the rising popularity of biosimilars may restrict the growth of the mammalian derived protein market globally.
Mammalian Derived Proteins Market: Overview
Tissue plasminogen activator (tPA), produced by Genentech Inc. in 1987 was the first approved biologic from mammalian tissue. Today, mammalian derived proteins dominates the market: out of the 58 biopharmaceutical products approved during 2006 and 2010, 32 were mammalian derived proteins, 17 were prokaryote derived, four in yeast, three in transgenic animals, and two in insect cultures. As a part of building the expertise through acquisition or collaboration strategy, several mergers, acquisitions and collaborations occurred in the recent past that is believed to drive the mammalian derived proteins market. In 2017, Lonza’s acquisition of Capsugel is closely aligned with its growth strategy and deliver value throughout the value chain. Similarly, in 2017, Thermo Fisher Scientific’s acquisition of contract development and manufacturing organization (CDMO) Patheon, has added value to their clinical trials and bio-production technologies.
Mammalian Derived Proteins Market: Regional Overview
North America will lead mammalian derived protein market due to technological development and premier research institutes in the U.S. and Canada. High prevalence and incidence of chronic diseases along with rising infertility issues in couples and the development of new products in this region will trigger the growth of mammalian derived protein market. After North America, Europe will lead to the growth of mammalian derived protein market due to rising chronic disease prevalence and ageing population. The strong healthcare payer-provider structure will fuel the growth of mammalian derived protein market. Asia-Pacific is estimated to show attractive growth for mammalian derived protein market due to rising prevalence of cardiac diseases in India and China. Africa, Latin America and Middle East regions are expected to show slower growth for mammalian derived protein market due to less awareness among the people in this region. .
Mammalian Derived Proteins Market: Key Players
Examples of some of the market participants in Mammalian derived proteins market identified across the value chain chain F. Hoffmann-La Roche AG, Merck KGaA, Eli Lilly and company, Lonza group AG, Cusabio Technology LLC., Prospec-Tany Technogene Ltd, Randox Laboratories Ltd, Geno Technology Inc., Kaneka and Eurogentec S.A., Batavia Biosciences, Abnova Corporation, Cayman Chemical Company., Geltor IndieBio, Bioclone Inc., and others.
The research report on Mammalian derived proteins market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on Mammalian derived proteins market provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on Mammalian derived proteins Market:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Report on Mammalian derived proteins market includes regional analysis:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil, Argentina)
- Europe (Germany, Italy, France, U.K, Spain, , Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report on Mammalian derived proteins market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Mammalian Derived Proteins Market: Segmentation
The global Mammalian derived proteins market is classified on the basis of product type, therapy area, application and end user and geographic region.
Based on product type, Mammalian derived proteins market is segmented into following:
- Monoclonal antibodies
- Clotting factors
Based on therapy area, Mammalian derived proteins market is segmented into following:
- Cancer Therapies
- Myocardial Infarction
- Congestive Heart Failure
- Crohn’s Disease
- Fertility Treatments
Based on application, Mammalian derived proteins market is segmented into following:
- Aptamer development
- Western blotting
- Protein Interaction
- Protein Structure
- Cell culture experiments
- Antibody profiling
- Improved altered functions
Based on end user, Mammalian derived proteins market is segmented into following:
- Biotechnology companies
- Research institutes
- Contract Research organizations
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.